48 related articles for article (PubMed ID: 15389512)
1. Prostate-Specific Antigen as an Ultrasensitive Biomarker for Patients with Early Recurrent Prostate Cancer: How Low Shall We Go? A Systematic Review.
von Eyben FE; Kairemo K; Kapp DS
Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672176
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Exposure to Supraphysiological Levels of Testosterone Impacts Rat Submandibular Gland Proteome.
Valente-Santos J; Vitorino R; Sousa-Mendes C; Oliveira P; Colaço B; Faustino-Rocha AI; Neuparth MJ; Leite-Moreira A; Duarte JA; Ferreira R; Amado F
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203721
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen: An unfamiliar protein in the human salivary glands.
Isola M; Maxia C; Murtas D; Ekström J; Isola R; Loy F
J Anat; 2024 May; 244(5):873-881. PubMed ID: 38111134
[TBL] [Abstract][Full Text] [Related]
4. PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates.
Veach DR; Storey CM; Lückerath K; Braun K; von Bodman C; Lamminmäki U; Kalidindi T; Strand SE; Strand J; Altai M; Damoiseaux R; Zanzonico P; Benabdallah N; Pankov D; Scher HI; Scardino P; Larson SM; Lilja H; McDevitt MR; Thorek DLJ; Ulmert D
Clin Cancer Res; 2021 Apr; 27(7):2050-2060. PubMed ID: 33441295
[TBL] [Abstract][Full Text] [Related]
5. Preparation of Enzyme-Activated Thapsigargin Prodrugs by Solid-Phase Synthesis.
Zimmermann T; Christensen SB; Franzyk H
Molecules; 2018 Jun; 23(6):. PubMed ID: 29914143
[TBL] [Abstract][Full Text] [Related]
6. Personalized ex vivo multiple peptide enrichment and detection of T cells reactive to multiple tumor-associated antigens in prostate cancer patients.
Taborska P; Stakheev D; Strizova Z; Vavrova K; Podrazil M; Bartunkova J; Smrz D
Med Oncol; 2017 Sep; 34(10):173. PubMed ID: 28866803
[TBL] [Abstract][Full Text] [Related]
7. Preclinical imaging of kallikrein-related peptidase 2 (hK2) in prostate cancer with a (111)In-radiolabelled monoclonal antibody, 11B6.
Timmermand OV; Ulmert D; Evans-Axelsson S; Pettersson K; Bjartell A; Lilja H; Strand SE; Tran TA
EJNMMI Res; 2014 Dec; 4(1):51. PubMed ID: 26116115
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric MRI for recurrent prostate cancer post radical prostatectomy and postradiation therapy.
Barchetti F; Panebianco V
Biomed Res Int; 2014; 2014():316272. PubMed ID: 24967355
[TBL] [Abstract][Full Text] [Related]
9. Low detectable prostate specific antigen after radical prostatectomy--treat or watch?
Koulikov D; Mohler MC; Mehedint DC; Attwood K; Wilding GE; Mohler JL
J Urol; 2014 Nov; 192(5):1390-6. PubMed ID: 24859441
[TBL] [Abstract][Full Text] [Related]
10. The incremental value of contrast-enhanced MRI in the detection of biopsy-proven local recurrence of prostate cancer after radical prostatectomy: effect of reader experience.
Wassberg C; Akin O; Vargas HA; Shukla-Dave A; Zhang J; Hricak H
AJR Am J Roentgenol; 2012 Aug; 199(2):360-6. PubMed ID: 22826397
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen kallikrein and the heart.
Patanè S
World J Cardiol; 2009 Dec; 1(1):23-5. PubMed ID: 21160572
[TBL] [Abstract][Full Text] [Related]
12. Evidence for the novel expression of human kallikrein-related peptidase 3, prostate-specific antigen, in the brain.
Stone JG; Rolston RK; Ueda M; Lee HG; Richardson SL; Castellani RJ; Perry G; Smith MA
Int J Clin Exp Pathol; 2009; 2(3):267-74. PubMed ID: 19079621
[TBL] [Abstract][Full Text] [Related]
13. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids.
Lövgren J; Valtonen-André C; Marsal K; Lilja H; Lundwall A
J Androl; 1999; 20(3):348-55. PubMed ID: 10386814
[TBL] [Abstract][Full Text] [Related]
14. Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages.
Corey E; Arfman EW; Oswin MM; Melchior SW; Tindall DJ; Young CY; Ellis WJ; Vessella RL
Urology; 1997 Aug; 50(2):184-8. PubMed ID: 9255285
[TBL] [Abstract][Full Text] [Related]
15. Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes.
Shariat SF; Roudier MP; Wilcox GE; Kattan MW; Scardino PT; Vessella RL; Erdamar S; Nguyen C; Wheeler TM; Slawin KM
Cancer Res; 2003 Aug; 63(15):4662-70. PubMed ID: 12907647
[TBL] [Abstract][Full Text] [Related]
16. The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease.
Becker C; Noldus J; Diamandis E; Lilja H
Crit Rev Clin Lab Sci; 2001 Oct; 38(5):357-99. PubMed ID: 11720279
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific human kallikrein (hK2) as a novel marker for prostate cancer.
Young CY; Seay T; Hogen K; Charlesworth MC; Roche PC; Klee GG; Tindall DJ
Prostate Suppl; 1996; 7():17-24. PubMed ID: 8950360
[TBL] [Abstract][Full Text] [Related]
18. Expression of prostate-specific antigen (PSA) and human glandular kallikrein 2 (hK2) in ileum and other extraprostatic tissues.
Olsson AY; Bjartell A; Lilja H; Lundwall A
Int J Cancer; 2005 Jan; 113(2):290-7. PubMed ID: 15389512
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
